![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Adis International
ISSN: 1173-5503
Source: PharmacoEconomics and Outcomes News, Vol.1, Iss.382, 2002-01, pp. : 8-8
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Willingness to pay for asthma linked to disease severity, QOL
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 361, 2002-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Formoterol/salbutamol: Poor asthma control in an elderly patient: case report
Reactions Weekly, Vol. 1, Iss. 1224, 2008-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Poor QOL linked to high future resource use in arthritis
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 376, 2002-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
High costs and poor adherence: major hurdles for bipolar disorder
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 637, 2011-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
QOL high with guideline-based asthma control
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 383, 2002-01 ,pp. :